|
KMID : 1141720190070010041
|
|
폐쇄성폐질환
2019 Volume.7 No. 1 p.41 ~ p.48
|
|
|
|
|
Jhun Byung-Woo
|
|
|
Abstract
|
|
|
|
Bronchiectasis is characterized by bronchial wall inflammation and damage, with irreversible dilatation of bronchi, resulting in a predisposition to impairment of mucociliary clearance and colonization by pathogenic microorganisms. This creates a potential vicious circle of infection, inflammation, and airway damage. A diagnosis of bronchiectasis is made by visual identification of an airway with a diameter greater than the accompanying artery and a lack of airway tapering in the periphery of the lung parenchyma or close proximity to the pleura. Bronchiectasis shows a wide range of presentations, from patients with almost no symptoms who have infrequent exacerbations to those with severe symptoms, frequent exacerbations, and major structural damage to the lung, which may even require lung transplantation. However, management of bronchiectasis is challenging, mainly because of the heterogeneity of the population at risk. The initial severity assessment of bronchiectasis is important as the disease severity score represents useful information for healthcare workers. Severity scores allow physicians to select patients in need of more aggressive treatment to reduce complications at an early stage. In addition, severity scores are informative for caregivers, who in turn will be better prepared to inform patients about their prognosis and expected morbidity. At present, several scales can be used to assess the severity and prognosis of bronchiectasis. This article regarding the diagnosis of bronchiectasis and predictive models will be helpful for physicians to manage patients with bronchiectasis.
|
|
|
KEYWORD
|
|
|
Bronchiectasis, Diagnosis, Severity
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|